06.11.2024  17:00:45 Zm. +0,80 Wolumen Bid17:00:45 Ask17:00:45 Kapitalizacja Rynkowa St. dywidendy Wskaźnik C/Z
257,20DKK +0,31% 160 207
Obrót: 19,92 mln
-Wolumen Bid: - -Wolumen Ask: - 56,36 mldDKK - 31,79

Opis działalności

Demant is a world-leading hearing healthcare and technology group built on a heritage of care, health and innovation since 1904. The Group offers innovative technologies, solutions and know-how to help improve people’s health and hearing. In every aspect, from hearing care, hearing aids and hearing implants to diagnostic equipment and services and audio solutions, Demant is active and engaged. Headquartered in Denmark, the Group employs approx. 16,500 people globally and is present with solutions in 130 countries where we create life-changing hearing health. William Demant Foundation holds the majority of shares in Demant A/S, which is listed on Nasdaq Copenhagen as a blue chip stock.
 

Zarząd & Rada nadzorcza

CEO
Søren Nielsen
Zarząd
René Schneider, Niels Wagner
Rada nadzorcza
Niels B. Christiansen, Niels Jacobsen, Thomas Duer, Charlotte Hedegaard, Heidir Hørby, Sisse Fjelsted Rasmussen, Kristian Villumsen
 

Dane firmy

Nazwa: Demant A/S
Adres: Kongebakken 9,DK-2765 Smørum
Telefon: +45-3917-7300
Fax: +45-3927-7900
E-mail: info@demant.com
Internet: www.demant.com/
Przemysł: Przemysł
Sektor: Inżynieria
Podsektor: -
Koniec roku finansowego: 31.12
Free float: 39,27%
Data IPO: -

Relacje inwestorskie

Nazwa: Peter Pudselykke
Telefon: +45-3917-7300
Fax: -
E-mail: pepu@demant.com

Główni akcjonariusze

The William Demant Foundation
 
58,00%
Inne
 
42,00%